Treatment

UW discovery could lead to new TB treatments

MADISON -The family of bacteria that causes tuberculosis (TB) and leprosy are notoriously sturdy. And although the diseases they cause have been held in check for the past 50 years by antibiotics, some strains are becoming increasingly resistant to existing therapy. Now, however, a new chink has been found in the cellular armor that makes these infectious diseases difficult to treat. The...

Standard Imaging acquires Canadian PIPSpro radiation treatment technologies

Middleton, Wis. s assets. Among the assets acquired from the British Colum...

Standard Imaging acquires Canadian PIPSpro radiation treatment technologies

Middleton, Wis. assets. Among the assets acquired from the British Colu...

FDA approves Bone Cares Hectorol for treatment of kidney disease

Middleton, Wis. -- announced Monday the U.S. Food and Drug Administration approved a new indication and strength for Hectorol (doxercalciferol) Capsules. Hectorol, a pro-hormone vitamin D2 analog, is currently approved for the treatment of secondary hyperparathyroidism (SHPT) in dialysis patients in the United Sta...

Unique Surface Treatment of Novel TSK-GEL ODS Columns Provide Separation of Aqueous and Fat Soluble Vitamins

With the introduction of two new reversed-phase column types, TSKgel ODS-100V and TSKgel ODS-100Z, excellent chromatographic performance and selectivity can be achieved for a wide range of sample types. TSKgel ODS-100Z and TSKgel ODS-100V are based on a spherical, five micron, silic...

Improve Recovery and Reproducibility with Pre-Treatment of Analytical TSK-GEL G3000SWXL Size Exclusion Columns

During a recent method optimization and investigation at Wyeth BioPharma, pre-treatment with bovine serum albumin improved reproducibility and recovery during the analytical SEC analysis of fractions pulled from a multi-ste...

Quintessence cancer treatment chosen for clinical studies

Quintessence said that pending a favorable preclinical safety assessment, it would submit to the <a href="http://w...

ZyStor to exhibit cell disorder treatments

As a presenter at the conference, Peterson will represent Wisconsin biotechnology companies with another presenter, Dr. Irene Hrusovsky, CEO of Madison-...

Radiology advance points way to non-invasive brain-cancer treatment

Glioblastoma Multiforme, GBM, is a brain cancer death sentence. Of the approximately 12,000 people who are diagnosed with GBM annually in the U.S., half will die within a year, and the rest within 3 years. The only treatments that stretch survival limits are exceptionally invasive surgeries to remove the tumor and radiation treatment with the maximum tolerated dose - all of which leads t...

Animal testing: Beyond the protests, instances of mistreatment are rare

Beyond the passion, however, exist facts about animal-based research that run counter to the intimidating tactics of some protesters, such as those who recently...

TomoTherapy leads the industry in CT image-guided treatments

In just over two and a half years, TomoTherapy's clinical centers have performed CT imaging before treatment delivery in upwards of 95% of their cases treated with the To...

Medical College getting $18.1 million to study radiation damage treatments

The institute is one of seven centers being funded by the <a href="http://ww...

`Single-sales factor' extends tax treatment to tech, service firms

With bipartisan support from the Legislature, Doyle embraced...

Research on fruit flies opens up possibilities for human treatments

The study, authored by researchers including UW-Madison molecular ge...

UW-Madison rat experiment could lead to stem-cell treatment for ALS

The researchers inserted human stem cells derived from fetal brain tissue into the spinal cords of rats afflicted with ALS, a disease th...

Wisconsin doctors pinpoint cancer with TomoTherapy radiation treatment

announced last week that its Hi-Art System, a pinpoint radiation treatment, is being used in 20 institutions in North America, including <a href="http://www.froedte...

WARF licenses patents for new glaucoma drug treatment

The patents are based on research conducted by <a target="blank" href="http://www.wisc.edu/kaufmanla...

Cancer treatment advances as trials show no harm to mice

said at a recent conference. Information supporting this conclusion was presented on October 7 at Bi...

OpGen joins UW, Henry Ford Heath in Improving Brain Tumor Treatment

Madison, Wis. -- Hermelin Brain Tumor Center</...

Biotech Pioneer Discusses Breakthrough in Osteoporosis Treatment

Deltanoid founder and CEO Hector DeLuca has discovered and characterized a promising chemically modified Vitamin D compound, 2MD, which reverses the effects of osteoporosis. In animal studies, 2MD increases bone growth while leaving blood calcium levels unchanged even at doses 3,000 times the level of other compounds. According to DeLuca, Vitamin Ds main job is to regulate calcium level...